NO166324C - Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer. - Google Patents

Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer.

Info

Publication number
NO166324C
NO166324C NO881775A NO881775A NO166324C NO 166324 C NO166324 C NO 166324C NO 881775 A NO881775 A NO 881775A NO 881775 A NO881775 A NO 881775A NO 166324 C NO166324 C NO 166324C
Authority
NO
Norway
Prior art keywords
kinolinamines
heteroalkyl
preparation
therapeutic active
analogue procedure
Prior art date
Application number
NO881775A
Other languages
English (en)
Norwegian (no)
Other versions
NO166324B (no
NO881775D0 (no
NO881775L (no
Inventor
Gregory Michael Shutske
Richard Charles Effland
Original Assignee
Hoechst Roussel Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Roussel Pharma filed Critical Hoechst Roussel Pharma
Publication of NO881775D0 publication Critical patent/NO881775D0/no
Publication of NO881775L publication Critical patent/NO881775L/no
Publication of NO166324B publication Critical patent/NO166324B/no
Publication of NO166324C publication Critical patent/NO166324C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
NO881775A 1987-04-23 1988-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer. NO166324C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US4156287A 1987-04-23 1987-04-23

Publications (4)

Publication Number Publication Date
NO881775D0 NO881775D0 (no) 1988-04-22
NO881775L NO881775L (no) 1988-10-24
NO166324B NO166324B (no) 1991-03-25
NO166324C true NO166324C (no) 1991-07-03

Family

ID=21917178

Family Applications (1)

Application Number Title Priority Date Filing Date
NO881775A NO166324C (no) 1987-04-23 1988-04-22 Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer.

Country Status (18)

Country Link
EP (1) EP0287977B1 (da)
JP (1) JP2835050B2 (da)
KR (1) KR960006392B1 (da)
AR (1) AR246971A1 (da)
AT (1) ATE107930T1 (da)
AU (1) AU609122B2 (da)
CA (1) CA1322368C (da)
DE (1) DE3850436T2 (da)
DK (1) DK174628B1 (da)
ES (1) ES2056849T3 (da)
FI (1) FI89801C (da)
IE (1) IE64197B1 (da)
IL (1) IL86158A (da)
NO (1) NO166324C (da)
NZ (1) NZ224313A (da)
PH (1) PH24884A (da)
PT (1) PT87287B (da)
ZA (1) ZA882811B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5202440A (en) * 1987-10-05 1993-04-13 Pfizer Inc. Certain 9-amino-2-(or 4)-oxa 1,2,3,4-tetrahydro- or 1,2,3,4,5,6,7,8-octahydro-acridines
IL87861A0 (en) * 1987-10-05 1989-03-31 Pfizer 4-aminopyridine derivatives
JP2720517B2 (ja) * 1989-05-31 1998-03-04 三菱化学株式会社 ９―アシルアミノーテトラヒドロアクリジン誘導体および該誘導体を有効成分とする記憶障害改善剤
ES2042384B1 (es) * 1991-12-26 1994-06-01 Boehringer Ingelheim Espana Procedimiento para obtener derivados bis-piridinicos.
EP1604653A1 (en) 1998-09-30 2005-12-14 Takeda Pharmaceutical Company Limited Acetylcholinesterase inhibitors for improving excretory potency of urinary bladder

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3674790A (en) * 1970-05-01 1972-07-04 American Home Prod 2,10-disubstituted-1,2,3,4-tetrahydrobenzo(bhq (1,6)naphthyridines useful as cns depressants
ES431307A1 (es) * 1973-11-16 1976-09-01 Thomae Gmbh Dr K Procedimiento para la preparacion de nuevos derivados de quinoleina.
GB8610980D0 (en) * 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
JPS63264485A (ja) * 1986-12-29 1988-11-01 Sumitomo Pharmaceut Co Ltd アミノキノリン誘導体

Also Published As

Publication number Publication date
EP0287977A2 (en) 1988-10-26
NO166324B (no) 1991-03-25
FI89801C (fi) 1993-11-25
IL86158A0 (en) 1988-11-15
EP0287977A3 (en) 1989-09-06
AU1509988A (en) 1988-10-27
DK222888A (da) 1988-10-24
IE881214L (en) 1988-10-23
EP0287977B1 (en) 1994-06-29
DK222888D0 (da) 1988-04-22
DE3850436T2 (de) 1994-11-17
NO881775D0 (no) 1988-04-22
ATE107930T1 (de) 1994-07-15
NZ224313A (en) 1991-01-29
CA1322368C (en) 1993-09-21
ES2056849T3 (es) 1994-10-16
AR246971A1 (es) 1994-10-31
IE64197B1 (en) 1995-07-12
FI881873A (fi) 1988-10-24
PT87287B (pt) 1992-08-31
DE3850436D1 (de) 1994-08-04
NO881775L (no) 1988-10-24
FI881873A0 (fi) 1988-04-21
KR880012606A (ko) 1988-11-28
KR960006392B1 (ko) 1996-05-15
JPS63284175A (ja) 1988-11-21
DK174628B1 (da) 2003-07-28
PH24884A (en) 1990-12-26
ZA882811B (en) 1988-10-20
FI89801B (fi) 1993-08-13
JP2835050B2 (ja) 1998-12-14
IL86158A (en) 1994-08-26
AU609122B2 (en) 1991-04-26
PT87287A (pt) 1988-05-01

Similar Documents

Publication Publication Date Title
NO165843C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive n-6 -substituerte adenosiner.
NO169439C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive oxadiazoler
NO872946D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzensulfonamidoindanylforbindelser.
NO166367C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive tieno-1,4-diazepiner.
NO874153D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater.
NO903941D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
NO883485D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive piperidinyl-isokinolinforbindelser.
NO169963C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive, substituerte 3,4-dihydro-2h-benzopyraner
NO165071C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 7-(3-amino-1-pyrrolidinyl)-8-klor-1-cyklopropyl-6- fluor-1,4,-dihydro-4-okso-3-kinolin-karboksylsyre.
NO880667D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive arylpiperazinyl-alkylen-fenyl-heterocykliske forbindelser.
NO167146C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO167734C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive substituerte aminderivater.
NO873680D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive sulfonamido-etyl-forbindelser.
NO164899C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolylindolforbindelser.
NO894949L (no) Analogifremgangsmaate for fremstilling av terapeutisk virksomme benzopyranylpyrrolinonderivater.
NO162188C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazokinoliner.
NO168477C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO166324C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte heteroalkylen-kinolinaminer.
NO168530C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive benzoksazoninforbindelser.
NO165542C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 5-aryl-2,4-dialkyl-3h-1,2,4-triazol-3-thioner.
NO903939L (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kondenserte diazepinoner.
NO874780D0 (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater.
NO882281D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive pyrazinamider.
NO167144C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktiv imidazo (4,5-f) isokinolin-2-on.
NO163327C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive dihydropyridiner.